These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 287660)

  • 1. MBD children--variability in developmental patterns or growth inhibitory effect of stimulants?
    Kaffman M; Sher A; Bar-Sinai N
    Isr Ann Psychiatr Relat Discip; 1979 Mar; 17(1):58-66. PubMed ID: 287660
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth deficits in children treated with desipramine: a controlled study.
    Spencer T; Biederman J; Wright V; Danon M
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):235-43. PubMed ID: 1564024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten years of experience with 1,000 hyperactive children in a private practice.
    Eichlseder W
    Pediatrics; 1985 Aug; 76(2):176-84. PubMed ID: 4022690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of methylphenidate on time perception in children with attention-deficit/hyperactivity disorder.
    Baldwin RL; Chelonis JJ; Flake RA; Edwards MC; Feild CR; Meaux JB; Paule MG
    Exp Clin Psychopharmacol; 2004 Feb; 12(1):57-64. PubMed ID: 14769100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate and growth in hyperactive children. A controlled withdrawal study.
    Klein RG; Landa B; Mattes JA; Klein DF
    Arch Gen Psychiatry; 1988 Dec; 45(12):1127-30. PubMed ID: 3058088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth in stimulant-naive children with attention-deficit/hyperactivity disorder using cross-sectional and longitudinal approaches.
    Hanć T; Cieślik J
    Pediatrics; 2008 Apr; 121(4):e967-74. PubMed ID: 18381524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulant therapy in attention deficit/hyperactivity disorder.
    Baldwin RL
    J Ark Med Soc; 2003 Dec; 100(6):203-6. PubMed ID: 14661403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methylphenidate (Ritalin) treatment in attention deficit hyperactivity disorder].
    Shalev R; Gross-Tsur V
    Harefuah; 1997 May; 132(9):672-5. PubMed ID: 9225587
    [No Abstract]   [Full Text] [Related]  

  • 11. [A study of 10 children. Positive effects of central nervous system stimulants in hyperactivity and attention disorder].
    Erikson A; Sjögren H; Kjellberg E
    Lakartidningen; 1991 Sep; 88(38):3076-8. PubMed ID: 1921596
    [No Abstract]   [Full Text] [Related]  

  • 12. Objective and subjective measures of the pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled laboratory classroom setting.
    Swanson J; Wigal S; Greenhill L; Browne R; Waslick B; Lerner M; Williams L; Flynn D; Agler D; Crowley KL; Fineberg E; Regino R; Baren M; Cantwell D
    Psychopharmacol Bull; 1998; 34(1):55-60. PubMed ID: 9564199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to growth hormone in attention deficit hyperactivity disorder: effects of methylphenidate and pemoline therapy.
    Rao JK; Julius JR; Breen TJ; Blethen SL
    Pediatrics; 1998 Aug; 102(2 Pt 3):497-500. PubMed ID: 9685452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attentional capacity, a probe ERP study: differences between children with attention-deficit hyperactivity disorder and normal control children and effects of methylphenidate.
    Jonkman LM; Kemner C; Verbaten MN; Van Engeland H; Camfferman G; Buitelaar JK; Koelega HS
    Psychophysiology; 2000 May; 37(3):334-46. PubMed ID: 10860411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention deficit hyperactivity disorder and methylphenidate: the relationship between gross body weight and drug response in children.
    Rapport MD; DuPaul GJ; Kelly KL
    Psychopharmacol Bull; 1989; 25(2):285-90. PubMed ID: 2602521
    [No Abstract]   [Full Text] [Related]  

  • 16. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of methylphenidate on performance during the Test of Variables of Attention in children with attention deficit/hyperactivity disorder.
    Huang YS; Chao CC; Wu YY; Chen YY; Chen CK
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):219-25. PubMed ID: 17472588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does extended medication with amphetamine or methylphenidate reduce growth in hyperactive children?
    Sund AM; Zeiner P
    Nord J Psychiatry; 2002; 56(1):53-7. PubMed ID: 11869467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth and sexual maturation in children and adolescents with attention deficit hyperactivity disorder.
    Poulton A
    Curr Opin Pediatr; 2006 Aug; 18(4):427-34. PubMed ID: 16914999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.